Lexicon Pharmaceuticals LXRX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's other income (expense)?
- Lexicon Pharmaceuticals (LXRX) reported other income (expense) of $1.54M in Q1 2026.
- How has Lexicon Pharmaceuticals's other income (expense) changed year-over-year?
- Lexicon Pharmaceuticals's other income (expense) decreased by 30.5% year-over-year, from $2.22M to $1.54M.
- What is the long-term trend for Lexicon Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's other income (expense) has grown at a 167.9% compound annual growth rate (CAGR), from $134K to $6.91M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.